Clinical pathways considerations and key treatment strategies for hepatocellular carcinoma (HCC) are discussed by a panel of medical experts.
EP. 1: Evaluating Clinical Pathway Implementation in HCC Treatment
A panel of medical experts open a discussion surrounding key treatment strategies in management of hepatocellular carcinoma (HCC).
EP. 2: The Impact of Clinical Pathways on Healthcare Resource Allocation in HCC Management
Ghassan Abou-Alfa, MD, MBA, and Mohamed Salem, MD, provide insights regarding potential clinical pathway-driven challenges associated with HCC management.
EP. 3: Identifying and Navigating Challenges Associated With Clinical Pathways in the Treatment of HCC
Ryan Haumschild, PharmD, MS, MBA, drives an expert discussion focused on challenges associated with clinical pathway utilization in treating patients with HCC.
EP. 4: Clinical Pathways and Streamlined Decision-Making in HCC Management
Benefits of clinical pathway implementation in HCC management are examined.
EP. 5: Patient Engagement and Clinical Pathways in HCC
Medical experts discuss patient considerations when utilizing clinical pathways in HCC treatment.
EP. 6: HIMALAYA Study and IMbrave150 Trial
An overview of the HIMALAYA study and IMbrave150 trial are provided.
EP. 7: Time-to-Response Correlation to HCC Treatment Effectiveness and Patient Prognosis
Expert panelists discuss key factors contributing to “time to response” in HCC treatment, and its impact on patient prognosis.
EP. 8: Navigating Adverse Events Associated With HCC Treatment
Dr Abou-Alfa discusses strategies to mitigate the impact of adverse events in patients receiving treatment for HCC.
EP. 9: Managing Adverse Events to Sustain Continuity in HCC Treatment
Treatment continuity and adherence in HCC can be encouraged through patient education and engagement.
EP. 10: Assessing Cost-Effective Treatment Options in HCC
Cost-effectiveness considerations are highlighted by Dr Abou-Alfa.
EP. 11: The Decision-Making Process Behind Elective Gastroscopy (EGD) in the Treatment of HCC.
The decision to perform an EGD is evaluated between academic and community health care perspectives.
EP. 12: Maximizing Health Care Resource Utilization in HCC
Richard Kim, MD, offers perspective regarding optimal use of health care resources in the management of HCC.
EP. 13: Key Toxicity Profiles in the Treatment of HCC
Dr Haumschild leads a discussion surrounding toxicity profiles specifically related to HCC.
EP. 14: Navigating HCC Treatment-Related Toxicities
Toxicity management in HCC treatment is discussed by medical experts.
2 Clarke Drive Cranbury, NJ 08512